Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma.

MLA

Rambaldi, Alessandro, et al. “Quantitative PCR of Bone Marrow BCL2/IgH+ Cells at Diagnosis Predicts Treatment Response and Long-Term Outcome in Follicular Non-Hodgkin Lymphoma.” Blood, vol. 105, no. 9, May 2005, pp. 3428–33. EBSCOhost, https://doi.org/10.1182/blood-2004-06-2490.

APA

Rambaldi, A., Carlotti, E., Oldani, E., Della Starza, I., Baccarani, M., Cortelazzo, S., Lauria, F., Arcaini, L., Morra, E., Pulsoni, A., Rigacci, L., Rupolo, M., Zaja, F., Zinzani, P. L., Barbui, T., & Foa, R. (2005). Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma. Blood, 105(9), 3428–3433. https://doi.org/10.1182/blood-2004-06-2490

Chicago

Rambaldi, Alessandro, Emanuela Carlotti, Elena Oldani, Irene Della Starza, Michele Baccarani, Sergio Cortelazzo, Francesco Lauria, et al. 2005. “Quantitative PCR of Bone Marrow BCL2/IgH+ Cells at Diagnosis Predicts Treatment Response and Long-Term Outcome in Follicular Non-Hodgkin Lymphoma.” Blood 105 (9): 3428–33. doi:10.1182/blood-2004-06-2490.